Welcome to CSAR, the Centre for the Studies of Asphyxia and Resuscitation, a neonatal research program that is unique in Canada. 

​

CSAR (Centre for the Studies of Asphyxia and Resuscitation) was established in 2014 to improve outcomes for newborn babies.  

​

CSAR's research focuses are to 1) understand basic respiratory, cardiovascular, neurological and metabolic changes during fetal to neonatal transition and 2) improve diagnoses, mitigate risk and improve survival and quality of life for newborns.

​

CSAR's research effort includes basic, simulation, translational, and clinical research to improve short- and long-term outcomes of newborn infants. 

​

CSAR is a training and innovation centre in Neonatal Resuscitation Research and a leader in research translation. CSAR is developing new research directions, influences guideline development and policy statements for national and international health communities. 

​

CSAR has an amazing research team with a focus on asphyxia and resuscitation, and on follow-up for outcomes (e.g. chronic lung disease and neurodevelopmental outcomes).

​

CSAR is participating and organizing a large number of randomized controlled trials, which makes CSAR a leading Neonatal Clinical Trial centre.

​

​

​

​

Neonatal resuscitation training for health professionals (RETAIN)

You are working in the Neonatal Intensive Care Unit (NICU), and have just been paged to the labor and delivery room. You are in a race against time.

Work through resuscitation scenarios based on real-life deliveries. Make decisions, perform tasks, manage stress, and work as a team to stabilize the baby.  Retain is a tabletop simulator to complement the existing neonatal training.

Retain is easily accessed on demand, helping medical professionals develop their resuscitation skills and knowledge anywhere, anyplace and anytime.

​

RETAIN was designed by a multidisciplinary team including Doctors, Nurses, Respiratory Therapist, Educators, Designers, and Computer Scientists to improve access to learning tools for everyone around the world.

 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​